Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ELOXX PHARMACEUTICALS, INC.

(ELOX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société ELOXX PHARMACEUTICALS, INC.
01/05ELOXX PHARMACEUTICALS, INC. : Notice of Delisting or Failure to Satisfy a Continued Listin..
AQ
2021ELOXX PHARMACEUTICALS : Topline ELX-02 Phase 2 Results Call and Webcast
PU
2021ELOXX PHARMACEUTICALS : Reports Positive Topline Results from Monotherapy Arms of Phase 2 ..
PU
2021ELOXX PHARMACEUTICALS, INC. : Regulation FD Disclosure, Other Events, Financial Statements..
AQ
2021Eloxx Pharmaceuticals Reports Positive Topline Results from Monotherapy Arms of Phase 2..
AQ
2021Eloxx Pharmaceuticals Reports Third Quarter 2021 Financial and Operating Results and Pr..
PU
2021Eloxx Pharmaceuticals Reports Third Quarter 2021 Financial and Operating Results and Pr..
AQ
2021ELOXX PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Conditio..
AQ
2021ELOXX PHARMACEUTICALS : Webcast and Conference Call
PU
2021ELOXX PHARMACEUTICALS : to Host Investor and Analyst Call and Webcast on Cystic Fibrosis P..
GL
2021ELOXX PHARMACEUTICALS, INC. : Entry into a Material Definitive Agreement, Termination of a..
AQ
2021HERCULES CAPITAL : Eloxx Pharmaceuticals Secures Debt Facility of Up to $30 Million from H..
AQ
2021ELOXX PHARMACEUTICALS, INC. : Entry into a Material Definitive Agreement, Other Events, Fi..
AQ
2021ELOXX PHARMACEUTICALS, INC. : Regulation FD Disclosure (form 8-K)
AQ
2021ELOXX PHARMACEUTICALS : Announces Fast Track Designation for ELX-02 for the Treatment of C..
AQ
2021ELOXX PHARMACEUTICALS : Appoints Chief Medical Officer
AQ
2021ELOXX PHARMACEUTICALS, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
2021ELOXX PHARMACEUTICALS : Reports Second Quarter 2021 Financial and Operating Results and Pr..
PU
2021ELOXX PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and Re..
AQ
2021ELOXX PHARMACEUTICALS : Reports Second Quarter 2021 Financial and Operating Results and Pr..
AQ
2021ELOXX PHARMACEUTICALS, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
2021ELOXX PHARMACEUTICALS : Provides Enrollment Update for Ongoing Phase 2 Clinical Studies fo..
PU
2021ELOXX PHARMACEUTICALS, INC. : Change in Directors or Principal Officers, Regulation FD Dis..
AQ
2021Eloxx Pharmaceuticals Provides Enrollment Update for Ongoing Phase 2 Clinical Studies f..
GL
2021ELOXX PHARMACEUTICALS : Financial Statements and Exhibits (form 8-K/A)
AQ
2021ELOXX PHARMACEUTICALS : Announces Funding Award from Cystic Fibrosis Foundation for Develo..
PU
2021ELOXX PHARMACEUTICALS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2021Eloxx Pharmaceuticals Announces Funding Award from Cystic Fibrosis Foundation for Devel..
GL
2021ELOXX PHARMACEUTICALS, INC. : Submission of Matters to a Vote of Security Holders (form 8-..
AQ
2021ELOXX PHARMACEUTICALS : Announces Closing of Public Offering of Common Stock Including Ful..
AQ
2021ELOXX PHARMACEUTICALS : Announces Closing of Public Offering of Common Stock Including Ful..
PU
2021ELOXX PHARMACEUTICALS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2021Eloxx Pharmaceuticals, Inc. Announces Closing of Public Offering of Common Stock Includ..
GL
2021ELOXX PHARMACEUTICALS, INC. : Entry into a Material Definitive Agreement, Financial Statem..
AQ
2021ELOXX PHARMACEUTICALS : Announces Pricing of Public Offering of Common Stock
AQ
2021ELOXX PHARMACEUTICALS : Announces Proposed Public Offering of Common Stock
AQ
2021ELOXX PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and Re..
AQ
2021Eloxx Pharmaceuticals Reports First Quarter 2021 Financial and Operating Results and Pr..
GL
2021ELOXX PHARMACEUTICALS : Adds Additional Treatment Arm to Ongoing Phase 2 Clinical Studies ..
PU
2021ELOXX PHARMACEUTICALS, INC. : Regulation FD Disclosure (form 8-K)
AQ
2021ELOXX PHARMACEUTICALS : Webcast and Conference Call
PU
2021ELOXX PHARMACEUTICALS : Acquires Zikani Therapeutics
AQ
2021ELOXX PHARMACEUTICALS, INC. : Entry into a Material Definitive Agreement, Completion of Ac..
AQ
2021ELOXX PHARMACEUTICALS, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
2021ELOXX PHARMACEUTICALS, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
2021ELOXX PHARMACEUTICALS : MANAGEMENT'S Discussion and analysis of financial condition and re..
AQ
2021Eloxx Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial and Operating..
GL
2021Eloxx Pharmaceuticals to Report Fourth Quarter and Full Year 2020 Financial Results and..
GL
2021Eloxx Announces Publication of Scientific Manuscript on ELX-02 in the Journal of Cystic..
GL
2021Eloxx Announces Publication of Scientific Manuscript on ELX-02 in the Journal of Clinic..
GL
2021ELOXX PHARMACEUTICALS : Announces Publication of Scientific Manuscript on ELX-02 in the Jo..
AQ
2021ELOXX PHARMACEUTICALS : Announces Cystic Fibrosis Foundation to Provide Increased Funding ..
AQ
2021ELOXX PHARMACEUTICALS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2021Eloxx Pharmaceuticals Announces Cystic Fibrosis Foundation (CF Foundation) To Provide I..
GL
2020ELOXX PHARMACEUTICALS : to Present at the Piper Sandler 32nd Annual Virtual Healthcare Con..
AQ
2020ELOXX PHARMACEUTICALS : to Present at the Piper Sandler 32nd Annual Virtual Healthcare Con..
AQ
2020Eloxx Pharmaceuticals to Present at the Piper Sandler 32nd Annual Virtual Healthcare Co..
GL
2020ELOXX PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and Re..
AQ
2020ELOXX PHARMACEUTICALS : Reports Third Quarter 2020 Financial and Operating Results and Pro..
AQ
2020Eloxx Pharmaceuticals Reports Third Quarter 2020 Financial and Operating Results and Pr..
GL
2020ELOXX PHARMACEUTICALS : Announces the Publication of Two Manuscripts on ELX-02 and it's ER..
AQ
2020ELOXX PHARMACEUTICALS : Announces The Publication of Two Manuscripts on ELX-02 and It's ER..
AQ
2020Eloxx Announces The Publication of Two Manuscripts on ELX-02 and It's ERSG Library In T..
GL
2020ELOXX PHARMACEUTICALS : Presents Two Preclinical Posters at the 2020 North American Cystic..
AQ
2020ELOXX PHARMACEUTICALS : Presents Two Preclinical Posters at the 2020 North American Cystic..
AQ
2020Eloxx Presents Two Preclinical Posters at the 2020 North American Cystic Fibrosis Virtu..
GL
2020ELOXX PHARMACEUTICALS : to Report Third Quarter 2020 Financial Results and Provide Busines..
AQ
2020ELOXX PHARMACEUTICALS : to Report Third Quarter 2020 Financial Results and Provide Busines..
AQ
2020Eloxx Pharmaceuticals to Report Third Quarter 2020 Financial Results and Provide Busine..
GL
2020ELOXX PHARMACEUTICALS : Globally Renowned Cystic Fibrosis Expert, Dr. Eitan Kerem, Joins E..
AQ
2020Globally Renowned Cystic Fibrosis Expert, Dr. Eitan Kerem, Joins Eloxx Pharmaceuticals ..
GL
2020ELOXX PHARMACEUTICALS : Globally Renowned Cystic Fibrosis Expert, Dr. Eitan Kerem, Joins E..
AQ
2020Eloxx Announces Two Preclinical Abstracts Accepted for Presentation at the 2020 North A..
GL
2020ELOXX PHARMACEUTICALS : Enrollment in the U.S. Phase 2 Clinical Trial in Cystic Fibrosis H..
AQ
2020Enrollment in the U.S. Phase 2 Clinical Trial in Cystic Fibrosis Has Resumed After Bein..
GL
1  2Next
Upcoming event on ELOXX PHARMACEUTICALS, INC.